InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Discover the detailed record of transactions filed by Wasman Jane, Director. Director active across 4 companies, notably RIGEL PHARMACEUTICALS INC. In total, 13 disclosures have been logged. Split: 1 buy · 0 sell. Total volume traded: €30k. Activity tracked since 19 May 2021. The latest transaction was disclosed on 7 January 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Wasman Jane
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations13 total
50,000 shares0Common StockSEC:0001104659-26-002491:0
20,000 shares@ US$1.69100.0% of flowCommon StockSEC:0001104659-25-055495:0
Canonical exit: 28 Aug 2025 (T+90)
2,500 shares0Common StockSEC:0000905148-25-001936:0
12,500 shares0Common StockSEC:0001104659-25-003498:0
25,000 shares0Common StockSEC:0000905148-24-001656:0
6,000 shares0Common StockSEC:0001104659-24-006397:0
25,000 shares0Common StockSEC:0001140361-23-034288:0
2,500 shares0Common StockSEC:0001104659-23-010629:0
22,321 shares0Common StockSEC:0001368148-23-000017:0
12,820 shares0Common StockSEC:0001368148-22-000131:0
25,000 shares0Common StockSEC:0001140361-22-020307:0
1,900 shares0Common StockSEC:0001104659-22-010400:0
25,000 shares0Common StockSEC:0001179110-21-005769:0
13 of 13 declarations
About Wasman Jane
Wasman Jane is Administrateur. She has 13 filings in total, and the sampled recent filings cover the period from 2021-05-21 to 2026-01-09. In that sample, buy volume is EUR 29705 and sell volume is EUR 0, with the dominant transaction nature indicated as Attribution.
